Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Maria Campbell

Nurse Practitioner Chula Vista, CA Nurse Practitioner

NPI 1154526986 CMS profile 10664434

752 Medical Center Ct, Ste 207, Chula Vista, CA 91911

Open in the dashboard

General payments

$13,233

324 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Maria Campbell of Chula Vista, CA is reported in the CMS Open Payments database as having received $13,233 across 324 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,228 44
2024 General $4,875 93
2023 General $3,562 114
2022 General $1,213 55
2021 General $355 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Maria Campbell
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Maria Campbell were reported at $3,228. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Maria Campbell Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $355 $135 $40–$426 $132
2022 $1,213 $152 $48–$470 $149
2023 $3,562 $166 $54–$529 $160
2024 $4,875 $173 $55–$556 $164
2025 $3,228 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $4,082 47 payments
  2. Boston Scientific Corporation $2,152 31 payments
  3. CVRx, Inc. $1,732 27 payments
  4. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $597 29 payments
  5. Abbott Laboratories $495 16 payments
  6. Shockwave Medical, Inc $488 2 payments
  7. Novartis Pharmaceuticals Corporation $425 30 payments
  8. Kiniksa Pharmaceuticals, Ltd. $262 12 payments
  9. Merck Sharp & Dohme Corporation $261 11 payments
  10. Janssen Pharmaceuticals, Inc $254 12 payments
  11. Other $2,486 107 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,606 309 payments
  2. Travel and Lodging $4,627 14 payments
  3. Education $1 1 payment
Products named General payments · program years 2021–2025
  1. Barostim Neo System $1,732 27 payments
  2. LINQ II $1,153 28 payments
  3. LifeVest $597 29 payments
  4. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $488 2 payments
  5. LEQVIO $320 24 payments
  6. VERQUVO $256 10 payments
  7. XARELTO $254 12 payments
  8. IMBRUVICA $211 11 payments
  9. LUX-Dx Insertable Cardiac Monitor $201 5 payments
  10. Ozempic $197 9 payments
  11. Other $4,315 179 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

324 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record